Breakthroughs in emotional awareness: Exploring sudden gains in internet-based psychodynamic therapy for depressed adolescents.

Psychother ResDec 8, 2025 (epub)
Clinical ResearchPsychiatryPediatrics

Arvid Treutiger, Erling Swedenmark, Karin Lindqvist et al.

✦ AI-curated · Sources linked

In 30 seconds

This qualitative analysis explored processes surrounding sudden gains (SGs) during internet-delivered psychodynamic therapy (IPDT) for adolescent depression. Drawing on a randomized controlled trial, researchers used reflexive thematic analysis to examine chat therapy sessions closely before and after an SG in 22 patients. In most cases, gains followed recurring patterns across multiple sessions: supported therapeutic effort, greater self-understanding through self-help materials, applying that understanding in daily life, and increased emotional awareness with less self-criticism. The findings suggest that SGs may reflect meaningful psychological experiences rather than statistical change alone.

Key findings

  • In most cases, SGs were preceded by recurring therapeutic processes extending across multiple sessions.
  • Patients described working with therapist support and using self-help materials to develop self-understanding.
  • Applying new understanding in everyday life was associated in patients’ accounts with greater emotional awareness and less self-criticism.

Why it matters

The analysis offers a process-based account of sudden improvement during online therapy for adolescent depression. It suggests that gains may emerge alongside sustained engagement, developing self-knowledge, and its application outside sessions, rather than as isolated changes. These themes may help clinicians interpret reported improvement in the context of the therapeutic work, while the qualitative findings do not establish which processes cause gains.

What to keep in mind

The analysis was qualitative and focused on 22 patients’ chat sessions around sudden gains; it does not establish causal mechanisms or show how broadly the themes apply.

Source

Published in Psychother Res. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.